These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 1503675)
21. Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population. Saito T; Ikeda M; Mushiroda T; Ozeki T; Kondo K; Shimasaki A; Kawase K; Hashimoto S; Yamamori H; Yasuda Y; Fujimoto M; Ohi K; Takeda M; Kamatani Y; Numata S; Ohmori T; Ueno S; Makinodan M; Nishihata Y; Kubota M; Kimura T; Kanahara N; Hashimoto N; Fujita K; Nemoto K; Fukao T; Suwa T; Noda T; Yada Y; Takaki M; Kida N; Otsuru T; Murakami M; Takahashi A; Kubo M; Hashimoto R; Iwata N Biol Psychiatry; 2016 Oct; 80(8):636-42. PubMed ID: 26876947 [TBL] [Abstract][Full Text] [Related]
22. Clozapine-induced agranulocytosis: Evidence for an immune-mediated mechanism from a patient-specific in-vitro approach. Regen F; Herzog I; Hahn E; Ruehl C; Le Bret N; Dettling M; Heuser I; Hellmann-Regen J Toxicol Appl Pharmacol; 2017 Feb; 316():10-16. PubMed ID: 27939987 [TBL] [Abstract][Full Text] [Related]
23. More than 25 years of genetic studies of clozapine-induced agranulocytosis. de With SAJ; Pulit SL; Staal WG; Kahn RS; Ophoff RA Pharmacogenomics J; 2017 Jul; 17(4):304-311. PubMed ID: 28418011 [TBL] [Abstract][Full Text] [Related]
25. Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C. McKnight C; Guirgis H; Votolato N Am J Psychiatry; 2011 Oct; 168(10):1120. PubMed ID: 21969051 [No Abstract] [Full Text] [Related]
26. Associations of HLA genotypes with antithyroid drug-induced agranulocytosis: A systematic review and meta-analysis of pharmacogenomics studies. Chen WT; Chi CC Br J Clin Pharmacol; 2019 Sep; 85(9):1878-1887. PubMed ID: 31108563 [TBL] [Abstract][Full Text] [Related]
27. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia. Combs MD; Perry PJ; Bever KA Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615 [TBL] [Abstract][Full Text] [Related]
28. Clozapine-induced agranulocytosis/granulocytopenia: mechanisms and monitoring. Wiciński M; Węclewicz MM Curr Opin Hematol; 2018 Jan; 25(1):22-28. PubMed ID: 28984748 [TBL] [Abstract][Full Text] [Related]
29. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Hägg S; Rosenius S; Spigset O Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898 [TBL] [Abstract][Full Text] [Related]
30. Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample. Dettling M; Cascorbi I; Roots I; Mueller-Oerlinghausen B Arch Gen Psychiatry; 2001 Jan; 58(1):93-4. PubMed ID: 11146763 [No Abstract] [Full Text] [Related]
31. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients. Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of clozapine-induced agranulocytosis. Gerson SL; Meltzer H Drug Saf; 1992; 7 Suppl 1():17-25. PubMed ID: 1503673 [TBL] [Abstract][Full Text] [Related]
33. Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis. Guest I; Sokoluk B; MacCrimmon J; Uetrecht J Toxicology; 1998 Nov; 131(1):53-65. PubMed ID: 9881934 [TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigen-DRB1*04:05 might be associated with the development of clozapine-induced agranulocytosis in a Japanese patient with schizophrenia. Hirakawa H; Terao T; Muronaga M; Ishii N Aust N Z J Psychiatry; 2020 May; 54(5):542-543. PubMed ID: 31718253 [No Abstract] [Full Text] [Related]
35. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis. Joffe G; Eskelinen S; Sailas E Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296 [No Abstract] [Full Text] [Related]
36. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina]. Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A Vertex; 2011; 22(96):94-7. PubMed ID: 21977603 [TBL] [Abstract][Full Text] [Related]
37. [Hematologic effects of clozapine: a review of the international experience]. Lamarque V Encephale; 1996 Dec; 22 Spec No 6():35-6. PubMed ID: 9102319 [TBL] [Abstract][Full Text] [Related]